Related Experiment Video

Updated: Nov 4, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K

Effect of Covid-19 quarantine on diabetes Care in Children

Miriannette Gayoso1, Whei Ying Lim1, Madhuri S Mulekar2

  • 1Department of Pediatrics, University of South Alabama, Strada Patient Care Center, 1601 Center St, Suite 1 S, Mobile, AL, 36604, USA.

Clinical Diabetes and Endocrinology
|May 22, 2021
PubMed

Insights

COVID-19 stay-at-home orders worsened glycemic control in children with type 1 diabetes. Children with public insurance experienced a greater increase in Hemoglobin A1c (A1c) levels compared to those with private insurance.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Diabetes Management

Background:

  • The COVID-19 pandemic led to widespread school closures and altered daily routines.
  • Management of pediatric diabetes required significant adaptation during this period.
  • Assessing the impact on glycemic control in children is crucial.

Purpose of the Study:

  • To evaluate the effect of COVID-19 stay-at-home orders on glycemic control in children with diabetes.
  • To compare Hemoglobin A1c (A1c) levels before and during the quarantine period.
  • To identify demographic or insurance-related factors influencing glycemic control changes.

Main Methods:

  • Retrospective review of 238 pediatric patients with type 1 and type 2 diabetes.
  • Comparison of average Hemoglobin A1c (A1c) levels from the year prior to quarantine (May 2019-April 2020) with levels during quarantine (May 2020-July 2020).
  • Statistical analysis using paired t-test and 2-sample t-test to assess changes and influencing factors.

Main Results:

  • Average A1c levels significantly increased from 9.2% to 9.5% during the quarantine period (p=0.0097).
  • The increase in A1c was significantly greater for patients with public insurance (0.49% increase) compared to private insurance (0.03% increase) (p=0.0137).
  • A significant association was found between insurance type and A1c change, with public insurance patients more likely to experience an increase.

Conclusions:

  • COVID-19 pandemic-related stay-at-home orders negatively impacted glycemic control in children with diabetes.
  • Children with type 1 diabetes on public insurance showed a disproportionately larger decline in glycemic control.
  • These findings highlight disparities in diabetes management during public health crises.
Abstract

Keywords:
COVID-19 quarantineDiabetesSchool nurse

More Related Videos

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.7K
Experimental Paradigm for Measuring the Effects of Self-distancing in Young Children07:01

Experimental Paradigm for Measuring the Effects of Self-distancing in Young Children

Published on: March 1, 2019

8.1K

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
661